News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
A healthcare-plan heavyweight is showing short-term pressure even as its 12-week performance remains positive.
Humana Inc. (HUM) shares fell 3.30% on Tuesday, closing at $362.16, despite a strong performance by the broader market with the S&P 500 Index and Dow Jones Industrial Average both rising significantly. The stock closed 15.56% below its 52-week high reached in mid-July.
This article first appeared on GuruFocus. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Delivered 16% organic growth with record volume gains across the business. Signed a definitive agreement …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the "Hotchkis & Wiley Mid-Cap Value Fund." A copy of the letter can be downloaded here. Equity markets posted strong returns in the second quarter of 2026, with the Russell …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana Inc. director Frederick John Crawford was granted 544 restricted stock units (RSUs) valued at $200,000 on August 1, 2026, as part of the company’s 2026 Stock Incentive Plan and annual Director Compensation Program. This award is contingent on his service for at least …
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Large Cap Strategy". A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index's 13.87% …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Janus Henderson Group PLC increased its stake in Humana Inc. by 8.8% in the first quarter, now holding 219,065 shares valued at $38.0 million. This comes as Humana reported strong second-quarter results, exceeding revenue and adjusted EPS expectations, although its unchanged full-year guidance and …
Humana Inc. (NYSE:HUM) has received a consensus "Hold" recommendation from 30 brokerages, with an average 12-month price target of $386.61. Despite exceeding second-quarter earnings expectations with adjusted EPS of $7.61 and revenue of $40.89 billion, the company's decision to maintain full-year guidance and exit …
Humacyte, Inc. (NASDAQ: HUMA) generated $2.04 million USD in revenue last year, primarily from its Acellular Human Tissues segment. This represents an increase from $1.56 million USD in the previous year, with the United States being the sole contributor to this revenue.
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by Humana Inc. (HUM). The firm is encouraging investors who purchased Humana securities prior to June 27, 2022, and still hold them, to come forward and assist with the investigation. The …
Amundi increased its stake in Humana Inc. by 9.0% in Q1, purchasing an additional 37,501 shares to own a total of 455,385 shares valued at $78.96 million. Other institutional investors also adjusted their holdings. Humana's stock performance saw mixed sentiment with analyst upgrades and …
Sharemaestro market context Trend signal active 52 weeks +31.5%HUM Q2 Deep Dive: Margin Initiatives, Operational Progress, and Medicare Advantage Strategy Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.89 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts' …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana Inc. has announced the election of Paul Smith and Frederick Crawford to its Board of Directors, effective immediately. Smith, Chief Commercial Officer at Anthropic PBC, brings over 30 years of experience in enterprise technology and scaling go-to-market strategies. Crawford, former President and COO …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Humana Inc. said Wednesday it plans to exit additional Medicare Advantage plans in 2027, a move expected to affect about 600,000 members. The insurer said the changes …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humacyte (HUMA) has received a notice from Nasdaq stating that its common stock failed to meet the minimum $1.00 bid price requirement for 30 consecutive business days. The company has until January 27, 2027, to regain compliance by maintaining a closing bid price of …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Humana has elected Paul Smith, Chief Commercial Officer at AI firm Anthropic, to its Board of Directors. The company has also elected Frederick …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Quick Read UnitedHealth (UNH) trims 1.1 million MA members as Humana (HUM) targets 25% growth, with both strategies already locked into 2027 benefit letters. Members whose plan exits have a 63-day guaranteed-issue Medigap window; miss it and insurers can medically underwrite, charge more, or …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Humana plans to shed approximately 600,000 members in 2027 by exiting certain markets and concentrating on higher-profitability insurance plans, many of which utilize value-based care. This strategic move aims to improve the company's margins, even as it faces rising treatment and drug costs. CEO …
SummitTX Capital L.P. recently acquired a new position in Humana Inc. (NYSE:HUM) valued at approximately $834,000. Several other institutional investors also adjusted their holdings in Humana, with 92.38% of the stock owned by institutional investors. The article details Humana's recent earnings, price performance, and …
Kentucky Retirement Systems significantly increased its stake in Humana Inc. by 69.8% in the first quarter of 2026, bringing its total holdings to 12,872 shares valued at approximately $2.23 million. This move comes as Humana exceeded second-quarter revenue and adjusted EPS expectations, although its …
This article provides a valuation analysis of Ihuman Inc (IH), highlighting its current valuation score of 7.41 and its P/E ratio of 5.24. It notes that the company ranks 335 out of 486 in the Software & IT Services industry, with its P/E ratio …
Piper Sandler has upgraded Humana Inc. (NYSE:HUM) to Overweight from Neutral, raising its price target to $463 due to an expected improvement in Individual Medicare Advantage margins and strong enterprise earnings growth. The firm anticipates margins to recover to 2.5% by calendar year 2028 …
Humana (HUM) Stock Trades Down, Here Is Why What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 7.2% in the afternoon session after the company reported a solid second-quarter earnings beat but was overshadowed by a concerning outlook for future profitability. The company …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Guggenheim has increased its price target for Humana Inc. (NYSE:HUM) to $471 from $269, maintaining a Buy rating, based on the health insurer's focus on Medicare Advantage margin expansion. Despite a recent stock dip after Q2 2026 results, Guggenheim projects significant annual margin recovery …
Search by ticker symbol or company name and select a result to open its chart.